Ameriprise’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.88M Buy
461,000
+124,211
+37% +$2.12M ﹤0.01% 1995
2025
Q1
$21.5M Buy
336,789
+25,776
+8% +$1.65M 0.01% 1266
2024
Q4
$37.8M Sell
311,013
-6,288
-2% -$765K 0.01% 986
2024
Q3
$39.6M Buy
317,301
+8,888
+3% +$1.11M 0.01% 953
2024
Q2
$48.7M Buy
308,413
+77,591
+34% +$12.3M 0.01% 810
2024
Q1
$29.9M Sell
230,822
-194
-0.1% -$25.1K 0.01% 1057
2023
Q4
$22.3M Sell
231,016
-522,189
-69% -$50.4M 0.01% 1208
2023
Q3
$91.3M Sell
753,205
-12,988
-2% -$1.57M 0.03% 531
2023
Q2
$87.7M Buy
766,193
+16,947
+2% +$1.94M 0.03% 552
2023
Q1
$103M Buy
749,246
+150,748
+25% +$20.8M 0.03% 480
2022
Q4
$77.6M Sell
598,498
-176,835
-23% -$22.9M 0.03% 559
2022
Q3
$85.7M Buy
775,333
+74,573
+11% +$8.24M 0.03% 502
2022
Q2
$52.2M Sell
700,760
-282,114
-29% -$21M 0.02% 702
2022
Q1
$76.8M Sell
982,874
-114,169
-10% -$8.92M 0.02% 630
2021
Q4
$98.8M Buy
1,097,043
+153,594
+16% +$13.8M 0.03% 577
2021
Q3
$87.6M Sell
943,449
-172,341
-15% -$16M 0.03% 559
2021
Q2
$86.7M Sell
1,115,790
-24,503
-2% -$1.9M 0.03% 574
2021
Q1
$85M Sell
1,140,293
-457,038
-29% -$34.1M 0.03% 567
2020
Q4
$272M Buy
1,597,331
+50,189
+3% +$8.56M 0.1% 225
2020
Q3
$217M Buy
1,547,142
+35,395
+2% +$4.97M 0.09% 239
2020
Q2
$242M Sell
1,511,747
-95,023
-6% -$15.2M 0.1% 209
2020
Q1
$157M Buy
1,606,770
+205,465
+15% +$20.1M 0.08% 241
2019
Q4
$181M Buy
1,401,305
+361,989
+35% +$46.7M 0.08% 266
2019
Q3
$78.3M Sell
1,039,316
-238,941
-19% -$18M 0.04% 492
2019
Q2
$194M Buy
1,278,257
+128,057
+11% +$19.5M 0.09% 241
2019
Q1
$137M Buy
1,150,200
+873,817
+316% +$104M 0.06% 314
2018
Q4
$30.2M Sell
276,383
-68,847
-20% -$7.52M 0.02% 843
2018
Q3
$55.8M Buy
345,230
+23,931
+7% +$3.86M 0.02% 699
2018
Q2
$42.2M Sell
321,299
-299,119
-48% -$39.3M 0.02% 744
2018
Q1
$46M Buy
620,418
+516,223
+495% +$38.2M 0.02% 704
2017
Q4
$5.8M Sell
104,195
-4,885
-4% -$272K ﹤0.01% 2021
2017
Q3
$4.95M Buy
109,080
+66,591
+157% +$3.02M ﹤0.01% 2095
2017
Q2
$1.43M Buy
42,489
+8,581
+25% +$289K ﹤0.01% 2767
2017
Q1
$544K Buy
33,908
+18,297
+117% +$294K ﹤0.01% 3137
2016
Q4
$428K Sell
15,611
-26,631
-63% -$730K ﹤0.01% 3338
2016
Q3
$2.59M Sell
42,242
-14,645
-26% -$899K ﹤0.01% 2422
2016
Q2
$1.09M Sell
56,887
-12,875
-18% -$246K ﹤0.01% 2837
2016
Q1
$1.36M Sell
69,762
-6,667
-9% -$130K ﹤0.01% 2711
2015
Q4
$2.95M Sell
76,429
-24,803
-25% -$957K ﹤0.01% 2391
2015
Q3
$3.25M Sell
101,232
-5,395
-5% -$173K ﹤0.01% 2295
2015
Q2
$3.25M Buy
106,627
+83,262
+356% +$2.53M ﹤0.01% 2421
2015
Q1
$311K Buy
+23,365
New +$311K ﹤0.01% 3403
2014
Q4
Sell
-20,155
Closed -$425K 4333
2014
Q3
$425K Buy
20,155
+19,930
+8,858% +$420K ﹤0.01% 3095
2014
Q2
$7K Sell
225
-295
-57% -$9.18K ﹤0.01% 4809
2014
Q1
$12K Buy
520
+425
+447% +$9.81K ﹤0.01% 4445
2013
Q4
$2K Sell
95
-48,168
-100% -$1.01M ﹤0.01% 4876
2013
Q3
$2.28M Sell
48,263
-190,035
-80% -$8.98M ﹤0.01% 2380
2013
Q2
$9.07M Buy
+238,298
New +$9.07M 0.01% 1492